Tumor LOH analysis provides reliable linkage information for prenatal genetic testing of sporadic NFI patients

Genes Chromosomes and Cancer

Volumn 46, Issue 9, 2007, Pages 820-827

  Serra, Eduard ^a   Pros, Eva ^a   García, Carles ^a   López, Eva ^a   Gili, M Lluïsa ^a   Gómez, Carolina ^a   Ravella, Anna ^b   Capellá, Gabriel ^a   Blanco, Ignacio ^c   Lázaro, Conxi ^a,d  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b Hospital Cruz Roja   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; GENE MUTATION; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC SCREENING; HAPLOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOSAICISM; MUTATION RATE; NEUROFIBROMATOSIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SOMATIC MUTATION;

DNA, NEOPLASM; GENES, NEUROFIBROMATOSIS 1; GENETIC COUNSELING; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MUTATION; NEUROFIBROMATOSIS 1; PEDIGREE;

EID: 34547130288     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20468     Document Type: Article

References (27)

1. Ars E, Kruyer H, Gaona A, Serra E, Lazaro C, Estivill X. 1999. Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation. Prenat Diagn 19:739-742.
2. Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X. 2000. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9:237-247; erratum in Hum Mol Genet 2000; 9:659.
3. Colman SD, Williams CA, Wallace MR. 1995. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11:90-92.
4. Daschner K, Assum G, Eisenbarth I, Krone W, Hoffmeyer S, Wortmann S, Heymer B, Kehrer-Sawatzki H. 1997. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem Biophys Res Commun 234:346-350.
5. DeBella K, Szudek J, Friedman JM. 2000. Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children. Pediatrics 105:608-614.
6. De Raedt T, Maertens O, Chmara M, Brems H, Heyns I, Sciot R, Majounie E, Upadhyaya M, De Schepper S, Spcleman F, Messiaen L, Vermeesch JR, Legius E. 2006. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients. Genes Chromosomes Cancer 45:893-904.
7. Eisenbarth I, Beyer K, Krone W, Assum G. 2000. Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas
8. of Patients with Neurofibromatosis Type 1. Am J Hum Genet 66:393-401.
9. Huson SM, Compston DA, Clark P, Harper PS. 1989. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26:704-711.
10. John AM, Ruggieri M, Ferner R, Upadhyaya M. 2000. A search for evidence of somatic mutations in the NF1 gene. J Med Genet 37:44-49.
11. Jovanovic BJ, Lew PS. 1997. A look at the rule of tree. Am Stat 51:137-139.
12. Kluwe L, Friedrich R, Mautner VF 1999. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma. Genes Chromosomes Cancer 24:283-285.
13. Krone W, Hogemann I. 1986. Cell culture studies on neurofibromatosis (von Recklinghausen). V. Monosomy 22 and other chromosomal anomalies in cultures from peripheral neurofibromas. Hum Genet 74:453-455.
14. Lazaro C, Gaona A, Ravella A, Volpini V, Estivill X. 1995. Prenatal diagnosis of neurofibromatosis type 1: From flanking RFLPs to intragenic microsatellite markers. Prenat Diagn 15:129-134.
15. Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T, De Schepper S, De Paepe A, Mortier G, Janssens S, Speleman F, Legius E, Messiaen L. 2006. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 27:1030-1040.
16. Messiaen LM, Gallons T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD. 2000. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541-555.
17. Peltonen J, Jaakola S, Lebwohl M. 1988. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760-771.
18. Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, Moose R, Virdi G, Roux K, Bauer M, Rojiani AM, Maria BL, Muir D, Wallace MR. 2000. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer 28:425-431.
19. Riccardi VM. 1992. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Baltimore: Johns Hopkins University Press.
20. Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D. 1996. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 14:110-112.
21. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, Estivill X, Lazaro C. 1997. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61:512-519.
22. Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard HG, Lazaro C. 2000. Schwann cells harbor the somatic NF1 mutation in neurofibromas: Evidence of two different Schwann cell subpopulations. Hum Mol Genet 9:3055-3064.
23. Serra E, Ars E, Ravella A, Sanchez A, Puig S, Rosenbaum T, Estivill X, Lazaro C. 2001a. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Hum Genet 108:416-429.
24. Serra E, Rosenbaum T, Nadal M, Winner U, Ars E, Estivill X, Lazaro C. 2001b. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat Genet 28:294-296.
25. Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, Thomas NS, Potts C, Griffiths S, Ruggieri M, von Deimling A, Cooper DN. 2004. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 23:134-146.
26. Vogelstein B, Kinzler KW. 2002. The Genetic Basis of Human Cancer, 2nd ed. New York: McGraw-Hill.
27. Wiest V, Eisenbarth I, Schmegner C, Krone W, Assum G. 2003. Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: Toward a theory of genetic modifiers. Hum Mutat 22:423-427.